Johnson Pharmacare Stock Screener | Share Price & Fundamental Analysis
JOHNPHARMA
Diversified Services
Screen Johnson Pharmacare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹0.60
▲
0.00 (0.00%)
Market Cap
₹33.05 Cr.
P/B Ratio
0.58
EPS (TTM)
₹-0.01
Dividend Yield
-
Debt to Equity
0.02
52W High
₹1.12
52W Low
₹0.58
Operating Margin
-
Profit Margin
-
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹58.00
Total Equity
₹56.00
Johnson Pharmacare Share Price History - Stock Screener Chart
Screen JOHNPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Johnson Pharmacare Company Profile - Fundamental Screener
Screen Johnson Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JOHNPHARMA shares.
Sector
Commercial Services
Industry
Diversified Services
Sub-Sector
Diversified Services
Segment
E
ISIN
INE560F01022
Johnson Pharmacare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen JOHNPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 |
| Current Assets | 1 | 0 | 0 | 1 | 6 | 5 | 5 | 4 | 4 | 22 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 58 | 60 | 60 | 60 | 60 | 59 | 60 | 60 | 59 | 59 |
| Current Liabilities | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 56 | 57 | 57 | 58 | 58 | 58 | 58 | 58 | 58 | 58 |
| Share Capital | 55 | 55 | 55 | 55 | 50 | 50 | 50 | 50 | 50 | 50 |
| Reserves & Surplus | 1 | 2 | 2 | 3 | 8 | 8 | 8 | 8 | 8 | 8 |
Screen JOHNPHARMA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 3 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 1 | 0 | 4 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| EBITDA | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | -53.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | -1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.02 | 0.00 | -0.01 | -0.02 | -0.03 | -0.01 |
Johnson Pharmacare Cash Flow Screener - Liquidity Fundamentals
Screen JOHNPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 0 | 0 | 5 | 0 | 0 | -1 | -1 | 11 | -11 |
| Investing Activities | 3 | 0 | -1 | -5 | 0 | 1 | 1 | 0 | -11 | 11 |
| Financing Activities | -1 | 0 | 1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen JOHNPHARMA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% | 85.56% |
| Other Holding | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% | 14.44% |
| Shareholder Count | 117,101 | 117,098 | 117,105 | 117,101 | 117,397 | 116,901 | 116,926 | 116,971 |
Johnson Pharmacare Dividend Screener - Share Yield Analysis
Screen JOHNPHARMA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Johnson Pharmacare Index Membership - Market Screener Classification
Screen JOHNPHARMA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Johnson Pharmacare Market Events Screener - Corporate Actions
Screen JOHNPHARMA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.72% | ||
| Annual General Meeting | NA | -1.28% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.59% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | -2.27% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 5.81% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -1.90% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.57% |
| 2022-04-07 | 2022-04-08 | Bonus | 1:10 | 30.97% |
| 2021-08-23 | 2021-08-23 | Change Of Name | NA | 0.00% |
Johnson Pharmacare Competitors Screener - Peer Comparison
Screen JOHNPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| International Gemmological Institute | 14,155 | 27.17 | 909 | -16.45% | 397 | 51.87 |
| Nesco | 8,879 | 21.38 | 865 | 10.15% | 375 | 50.86 |
| WeWork India Management | 7,876 | 60.86 | 2,024 | 16.51% | 130 | 43.35 |
| CMS Info Systems | 5,780 | 16.07 | 2,475 | 7.68% | 373 | 46.88 |
| Smartworks Coworking Spaces | 5,304 | -168.12 | 1,410 | 26.65% | -63 | 38.91 |
| SIS | 4,657 | 89.50 | 13,257 | 7.75% | 12 | 49.78 |
| Nirlon | 4,551 | 14.24 | 645 | 6.19% | 218 | 53.31 |
| Indiqube Spaces | 4,223 | -37.87 | 1,103 | 27.11% | -140 | 40.41 |
| Hemisphere Properties | 3,771 | -385.59 | 8 | -2.50% | -8 | 45.65 |
| Awfis Space Solutions | 3,577 | 68.58 | 1,261 | 44.11% | 68 | 39.64 |
Johnson Pharmacare Company Announcements - News Screener
Screen JOHNPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Change in Corporate Office Address | View |
| 2025-11-24 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Monday 24Th November 2025 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-14 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 14Th November 2025. | View |
| 2025-11-14 | Un-Audited Financial Results For The Quarter And Half Year Ended As On 30Th September 2025. | View |
| 2025-11-12 | Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025 | View |
| 2025-10-27 | Updation Pursuant To Second Proviso To Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Updation In Corporate Information On BSE Portal. | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Updation Pursuant To Second Proviso To Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Updation In Corporate Information On BSE Portal. | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-12 | Updation Pursuant To Second Proviso To Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-08-23 | Reg. 34 (1) Annual Report. | View |
| 2025-08-23 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-23 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-23 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-23 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd July 2025. | View |